Trial Details

RECRUITING
Basic Information
Clinical ID c1169
Identifier NCT06626165
Trial Title Association Between Effectiveness of Mirikizumab and UC Patients with High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Mirikizumab|DRUG: Vedolizumab
Participant Information
Sponsor Showa Inan General Hospital
City Komagane
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2024-07-20
Primary Completion Date 2025-12-31
Completion Date 2025-12-31